SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-354147
Filing Date
2017-11-28
Accepted
2017-11-28 17:18:06
Documents
8
Period of Report
2017-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d496359d8k.htm 8-K 19821
2 EX-1.1 d496359dex11.htm EX-1.1 199124
3 EX-5.1 d496359dex51.htm EX-5.1 13181
4 EX-99.1 d496359dex991.htm EX-99.1 10298
5 EX-99.2 d496359dex992.htm EX-99.2 11569
6 GRAPHIC g496359g24o58.jpg GRAPHIC 13717
7 GRAPHIC g496359g28r86.jpg GRAPHIC 13577
8 GRAPHIC g496359g68m76.jpg GRAPHIC 4705
  Complete submission text file 0001193125-17-354147.txt   299894
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 171226181
SIC: 2834 Pharmaceutical Preparations